Philips and Polarean have expanded their strategic partnership to bring advanced, radiation-free lung imaging to patients with obstructive lung diseases through the use of hyperpolarized Xenon-129 (¹²⁹Xe) MRI. This novel imaging technology allows clinicians to directly visualize how air flows through various regions of the lungs in real time, addressing a major limitation of traditional imaging methods. Integrated with Philips’ MR 7700 system and Polarean’s FDA-cleared XENOVIEW 3T Chest Coil, the platform enables fast, dual-modality imaging (Xenon and Proton) during two brief 10-second breath-holds, making it highly suitable for routine clinical use, especially in pediatric populations.

Chronic respiratory diseases such as asthma and COPD impact hundreds of millions globally, yet conventional imaging lacks the sensitivity to reveal detailed lung function. The Philips-Polarean collaboration offers a breakthrough in pulmonary diagnostics, particularly for children who often require frequent imaging and are vulnerable to the cumulative effects of radiation. The Xenon MRI technology provides clinicians with functional insights into regional lung ventilation without exposing patients to ionizing radiation, making it a safer, more accurate tool for early detection, treatment planning, and ongoing monitoring.

By merging Philips’ robust MRI infrastructure with Polarean’s cutting-edge Xenon imaging platform, this partnership sets a new standard in functional lung imaging. The initiative not only enhances diagnostic precision but also improves patient experience by reducing scan times and simplifying workflows. As the technology continues to gain traction and pending FDA approval for younger children, it promises to reshape respiratory care—bringing radiation-free, high-resolution lung imaging to the forefront of clinical practice and advancing outcomes for pediatric and adult patients alike.

MedTech Spectrum's Summary

Innovation in Lung Imaging: Philips and Polarean are expanding access to advanced, non-invasive Xenon MRI technology, enabling real-time visualization of lung ventilation without radiation exposure.

Improved Pediatric Care: The system, now integrated into Philips’ MRI workflow, allows for rapid, dual-modality scans suitable for children, offering safer and more accurate monitoring of conditions like asthma and cystic fibrosis.

Clinical Impact:This collaboration brings cutting-edge lung diagnostics into routine care,  supporting earlier detection, better disease management, and enhanced patient outcomes, particularly in pediatric and chronic lung disease populations.